search
Back to results

Maximising the Taste and Health Value of Plant Food Products (MAXVEG)

Primary Purpose

Type 2 Diabetes

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Diet intervention
Sponsored by
Aarhus University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Type 2 Diabetes focused on measuring Diet intervention, Type 2 diabetes, Vegetables, Phytochemicals

Eligibility Criteria

30 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 2 diabetes in diet treatment or on oral anti-diabetic drug or the metabolic syndrome.

Exclusion Criteria:

  • Other severe diseases or in treatment with insulin, GLP-1 analogs, glitazones.

Sites / Locations

  • Hospital Vendsyssel, Center for Clinical Research

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

No Intervention

Experimental

Arm Label

Diet intervention - Ancient vegatables

Control Nordic diet

Diet intervention - Modern Vegetables

Arm Description

A healthy Nordic diet with high content of bitter strong tasting vegetables and cabbages.

A diet habitually consumed in the Nordic countries

A healthy Nordic diet with high content of sweet and mild tasting vegetables and cabbages.

Outcomes

Primary Outcome Measures

Insulin sensitivity
Measured as the AUC from an Oral Glucose Tolerance Test

Secondary Outcome Measures

Urine and blood samples
The fasting blood samples will be analyzed for: glucose, insulin, glucagon, HbA1c, lipids (triglycerides, HDL-, LDL- and total cholesterol), cytokines (, adipokines biomarkers of oxidative stress parathyroid hormone, vitamin D and GLP-1. Urine samples for metabolomics (isoprostanes and water-soluble metabolites).

Full Information

First Posted
July 18, 2011
Last Updated
March 10, 2015
Sponsor
Aarhus University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01397942
Brief Title
Maximising the Taste and Health Value of Plant Food Products
Acronym
MAXVEG
Official Title
Maximising the Taste and Health Value of Plant Food Products - Impact on Vegetable Consumption, Consumer Preferences and Human Health Factors.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
May 2011 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
January 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aarhus University Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To investigate if a high dietary intake of bitter and strong tasting vegetables have positive health effects (insulin sensitivity, glucose tolerance, central obesity, fasting and postprandial lipid profile, blood pressure, vitamin D status and inflammatory markers, biomarkers of oxidative stress) on subjects with T2D. Also to look at a high dietary intake of mild and sweet modern vegetables or a normal western diet.
Detailed Description
The metabolic syndrome (MS), type 2 diabetes (T2D) and obesity are the world's most prevalent lifestyle diseases. This unfortunate development is mainly caused by lifestyle choices leading to obesity due to physical inactivity and excessive calorie intake. Vegetables are an important part of the human diet and a major source of biologically active substances which determine the nutritional quality of food, color, taste, smell, antioxidative, anticarcinogenic, antihypertensive, anti-inflammatory, antihyperglycemia, immunostimulating and cholesterol-lowering properties. Diet, as one aspect of lifestyle, is thought to be one of the modifiable variable risk factors for the development of MS and T2D, but more information is needed as to which components of the diet could be protective for the development and progression of MS and T2D with all its complications. The study will be carried out as a 3-month randomized controlled parallel intervention study involving 60 subjects with T2D. During the fall year 2011 30 (10 in each group) subjects will participate and the remaining 30 subjects (10 in each group) in the fall 2012. The subjects will be randomized into 3 different diets: A) "A healthy Nordic diet" with high content of bitter strong tasting vegetables and cabbages. B) "A healthy Nordic diet" with high content of sweet and mild tasting vegetables and cabbages. C) A diet habitually consumed in the Nordic countries (normal control diet). The subjects in groups A and B will each have to consume 500 g root vegetables and cabbages daily which will be handed out once a week. The participants will visit the study clinic at screening, and then once weekly during the intervention period (12 weeks). Beside the screening examination there will be 3 major visits (0, 6 and 12 weeks) where the participants will collect urine samples, complete a 3-day weighed food diary (to control diet intake) and undergo clinical examination incl. measuring of blood pressure, body composition and collection of fasting blood samples i.e. glucose, insulin, glucagon, HbA1c, GLP-1, lipids (triglycerides, HDL-, LDL- and total cholesterol), cytokines, adipokines, parathyroid hormone and vitamin D. During first (week 0) and third (week 12) major visit a 120 minutes oral glucose tolerance test is included collecting blood to analyze for glucose, insulin and triglycerides. The study will contribute to the understanding on the impact of a diet with a high level of root vegetables and cabbages with either high or low levels of phytochemicals. Furthermore, the results can be used to develop new recommendations targeted T2D and MS subjects, and thereby contribute to a healthier lifestyle and to prevent any further development and progression of these lifestyle diseases. The overall perspective of the MAXVEG project is to enhance the consumption and production of bitter and strong tasting health promoting root vegetables and cabbages with high phytochemical content and high consumer preferences targeted specific consumer groups

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
Keywords
Diet intervention, Type 2 diabetes, Vegetables, Phytochemicals

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
92 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diet intervention - Ancient vegatables
Arm Type
Experimental
Arm Description
A healthy Nordic diet with high content of bitter strong tasting vegetables and cabbages.
Arm Title
Control Nordic diet
Arm Type
No Intervention
Arm Description
A diet habitually consumed in the Nordic countries
Arm Title
Diet intervention - Modern Vegetables
Arm Type
Experimental
Arm Description
A healthy Nordic diet with high content of sweet and mild tasting vegetables and cabbages.
Intervention Type
Other
Intervention Name(s)
Diet intervention
Other Intervention Name(s)
Vegetables, Ancient, Cabbages, Type 2 diabetes
Intervention Description
The participants in the two experimental arms will each have to consume 500 g of vegetables and cabbages daily.
Primary Outcome Measure Information:
Title
Insulin sensitivity
Description
Measured as the AUC from an Oral Glucose Tolerance Test
Time Frame
2 years
Secondary Outcome Measure Information:
Title
Urine and blood samples
Description
The fasting blood samples will be analyzed for: glucose, insulin, glucagon, HbA1c, lipids (triglycerides, HDL-, LDL- and total cholesterol), cytokines (, adipokines biomarkers of oxidative stress parathyroid hormone, vitamin D and GLP-1. Urine samples for metabolomics (isoprostanes and water-soluble metabolites).
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 2 diabetes in diet treatment or on oral anti-diabetic drug or the metabolic syndrome. Exclusion Criteria: Other severe diseases or in treatment with insulin, GLP-1 analogs, glitazones.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Per B Jeppesen, Prof. PhD
Organizational Affiliation
University of Aarhus
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Vendsyssel, Center for Clinical Research
City
Hjørring
State/Province
Nordjylland
ZIP/Postal Code
9800
Country
Denmark

12. IPD Sharing Statement

Links:
URL
http://www.maxveg.dk
Description
Click here for more information about this study: Maximising the Taste and Health Value of Plant Food Products (MAXVEG)

Learn more about this trial

Maximising the Taste and Health Value of Plant Food Products

We'll reach out to this number within 24 hrs